Workflow
Alto Ingredients, Inc. to Release Fourth Quarter and Year-end 2025 Financial Results on March 4, 2026
Globenewswire· 2026-02-25 21:05
PEKIN, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its fourth quarter and year-end 2025 financial results after the close of market on Wednesday, March 4, 2026. Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time and will also deliver prepared remarks via webcast followed by a question-and-answer session. How to ...
TWFG Announces Fourth Quarter and Full Year 2025 Results
Globenewswire· 2026-02-25 21:05
– Total Revenues increased 33.0% for the quarter over the prior year period to $68.8 million – – Organic Revenue Growth Rate* of 11.7% for the quarter – – Net income of $14.4 million for the quarter – – Adjusted EBITDA* increased 56.9% for the quarter over the prior year period to $21.7 million - – Share Repurchase Authorization approved for up to $50 million - THE WOODLANDS, Texas, Feb. 25, 2026 (GLOBE NEWSWIRE) -- TWFG, Inc. (“TWFG”, the “Company” or “we”) (NASDAQ: TWFG), a high-growth insurance distribut ...
PSTL Announces BBB Investment Grade Rating from Kroll Bond Rating Agency (KBRA)
Globenewswire· 2026-02-25 21:05
CEDARHURST, N.Y., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,200 properties leased primarily to the United States Postal Service (the “USPS”), ranging from last-mile post offices to industrial facilities, announced that Postal Realty LP has received an investment grade credit rating of BBB with a Stable Outlook from Kroll Bond Rating Agency, LLC (“KBRA”). “Achieving an inaugural inv ...
Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026
Globenewswire· 2026-02-25 21:05
GAITHERSBURG, Md., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its fourth quarter 2025 financial results after market close on Wednesday, March 11, 2026. Members of the Company’s management team will host a conference call and webcast starting at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on the same day. The conference call can be accessed using the following information ...
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Globenewswire· 2026-02-25 21:05
FY 2025 Total Revenue of $510 Million, Representing 20% Year-Over-Year Growth FY 2025 ASCENIV Revenue Grew to $363 Million, Representing 51% Year-Over-Year Growth FY 2025 Adjusted Net Income(1) of $161 Million, Representing 35% Year-Over-Year Growth FY 2025 Adjusted EBITDA(2) of $231 Million, Representing 40% Year-Over-Year Growth Incoming CFO Appointment Expected to Further Enhance Financial Strategy, Working Capital Execution and Capital Allocation Discipline Advancing SG-001 Pipeline Program with Anticip ...
LeMaitre Q4 2025 Financial Results
Globenewswire· 2026-02-25 21:05
BURLINGTON, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q4 2025 results, announced a quarterly dividend of $0.25/share (+25%), and provided guidance. Q4 2025: Sales $64.5mm, +16% (+15% organic) vs. Q4 2024Gross margin 71.7% (+240 bps)Op. income $18.8mm (+47%)Op. margin 29%Diluted EPS $0.68 (+39%)Cash up $16.1mm sequentially to $359.1mm Grafts (+27%), valvulotomes (+20%), and carotid shunts (+18%) drov ...
CBIZ Reports Fourth-Quarter and Full-Year 2025 Financial Results
Globenewswire· 2026-02-25 21:05
Full Year Revenue Up 52% and EPS Up 135% Attributable to Acquisition, Integration Nearly Complete, 2026 Outlook Expects YoY Growth in Revenue, Profitability and Free Cash Flow, Significant Opportunities in Growth Initiatives, Offshoring and AI Full Year Financial Highlights: Total revenue of $2.8B, up 52.1%Net income of $115.4M, up 181.3%; GAAP EPS of $1.83, up 134.6% Adjusted EBITDA of $446.9M, up 125.5%; Adjusted diluted EPS of $3.61, up 79.6%Operating cash flow of $192.5M, up 55.6%; Free cash flow of $1 ...
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 13, 2026
Globenewswire· 2026-02-25 21:05
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 13, 2026, short interest in 3,595 Nasdaq Global MarketSM securities totaled 15,834,216,597 shares compared with 15,574,683,465 shares in 3,547 Global Market issues reported for the prior settlement date of January 30, 2026. The mid-January short interest represents 2.25 days compared with 2.58 days for the prior reporting period. Short interest in 1,654 securities on The Nasdaq Capital MarketSM totaled 3,724,995,849 sh ...
Ormat Technologies Reports Fourth Quarter and Year-End 2025 Financial Results
Globenewswire· 2026-02-25 21:05
STRONG FINANCIAL PERFORMANCE, STRATEGIC PORTFOLIO EXPANSION, AND NEW LONG-TERM PPAS, SUPPORT LONG-TERM GROWTH TARGETS HIGHLIGHTS TOTAL REVENUES FOR THE FULL-YEAR AND FOURTH QUARTER INCREASED 12.5% AND 19.6%, RESPECTIVELY, COMPARED TO 2024LONG-TERM PPA AGREEMENTS SIGNED WITH GOOGLE AND SWITCHADVANCING ENHANCED GEOTHERMAL SYSTEMS (EGS) THROUGH SLB JOINT VENTURE AND SAGE INVESTMENT AND COOPERATION AGREEMENTORMAT ANNOUNCES FULL YEAR 2026 OUTLOOK AND GROWTH EXPECTATIONS RENO, Nev., Feb. 25, 2026 (GLOBE NEWSWIRE ...
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
Globenewswire· 2026-02-25 21:05
FOSTER CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that members of senior management will be participating in the following upcoming investor conferences in March. TD Cowen's 46th Annual Health Care ConferenceFormat: Fireside ChatDate and Time: Monday, March 2, 2026 at 3:50 p.m. ET Location: Boston, MA Leerink Global Healthcare Conference Format: Fireside ChatDate and Time: Monday, M ...